Order Article Reprints

Lee I-C, Lee P-C, Chao Y, Chi C-T, Wu C-J, Hung Y-P, Su C-W, Hou M-C, Huang Y-H. Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment. Viruses. 2022; 14(11):2355. https://doi.org/10.3390/v14112355

Lee, I-Cheng, Pei-Chang Lee, Yee Chao, Chen-Ta Chi, Chi-Jung Wu, Yi-Ping Hung, Chien-Wei Su, Ming-Chih Hou, and Yi-Hsiang Huang. 2022. "Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment" Viruses 14, no. 11: 2355. https://doi.org/10.3390/v14112355

Lee, I.-C., Lee, P.-C., Chao, Y., Chi, C.-T., Wu, C.-J., Hung, Y.-P., Su, C.-W., Hou, M.-C., & Huang, Y.-H. (2022). Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment. Viruses, 14(11), 2355. https://doi.org/10.3390/v14112355